This was the opposite to hypoglycaemic diabetes medications insulin (RR 2.85; 95% CI 1.75–4.64)60 and sulfonylureas (RR 1.79; 95% CI 1.29–2.49)60 which showed evidence of a positive association with pancreatic cancer. This evidence concerns the gene INS and familial pancreatic carcinoma.